Multiple Australian outlets report that a new clinical trial is being set up to investigate whether psilocybin-assisted psychotherapy can help people experiencing long-term effects after mild traumatic brain injury, including concussion. The coverage describes the study as testing psilocybin in combination with structured psychological support rather than as a stand-alone treatment. The focus is on persistent symptoms that can follow mild traumatic brain injury, which may include cognitive and emotional difficulties, though the reports emphasize the trial’s purpose rather than specific outcomes. Across the sources, the key point is that researchers aim to evaluate the therapy’s potential effectiveness for concussion sufferers whose symptoms continue beyond the initial injury period. The articles do not indicate that results are available yet, describing the work as a forthcoming trial rather than a completed study. Overall, the reports present psilocybin-assisted psychotherapy as an emerging approach under formal clinical evaluation for long-term concussion-related effects.